Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Mymetics regains intranasal flu vaccine candidate from Solvay

Oct. 6, 2011

Gilead obtains worldwide rights for novel HIV integrase inhibitors from Boehringer Ingelheim

Oct. 6, 2011

Dynavax Technologies and AstraZeneca accelerate development of candidate asthma therapy

Oct. 6, 2011

Evotec confirms second collaboration with UCB

Oct. 6, 2011

Celgene and Agios Pharmaceuticals expand cancer metabolism partnership

Oct. 6, 2011

Merck Serono and Ono Pharmaceutical collaborate on MS drug and cancer vaccine

Oct. 5, 2011

Intellect Neurosciences and ViroPharma enter licensing agreement for OX-1

Oct. 5, 2011

MedImmune in-licenses tremelimumab from Pfizer

Oct. 4, 2011

Children's Oncology Group and Apeiron to collaborate on phase II study in neuroblastoma

Oct. 3, 2011

NanoCarrier and Kowa to enter worldwide agreement for NC-6300

Sep. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...